US Patent Issued to Crowd Pharma Losartan on Jan. 13 for "Use of losartan for the treatment of fibrotic diseases, in particular epidermolysis bullosa" (German, Swiss Inventors)

ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,521,373, issued on Jan. 13, was assigned to Crowd Pharma Losartan GmbH & Co. KG (Pforzheim, Germany).

"Use of losartan for the treatment of fibrotic diseases, in particular epidermolysis bullosa" was invented by Dimitra Kiritsi (Gundelfingen, Germany), Brigitte Stiller (Freiburg, Germany), Klas Alexander Nystroem (Basel, Switzerland) and Leena Kaarina Bruckner-Tuderman (Freiburg, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to Losartan for use in the treatment of a fibrotic disease, characterized in that a dose of 0.4-1.4 mg/kg body weight of the human patient is administered daily, whereby the fibrotic disease is...